SGLT2 inhibitors and lower limb complications: an updated meta‐analysisChu Lin, Linong Ji, Fang Lv et al.|Cardiovascular Diabetology|2021Cited by 82
Revisiting the association between sodium-glucose cotransporter-2 inhibitors and the risk of neoplasm in patients with type 2 diabetes: new insights from an updated systematic review and meta-analysis of randomized controlled trialsY. Wang, Linong Ji, Fang Lv et al.|Expert Review of Clinical Pharmacology|2025Cited by 2
The association between the eGFR slope and cardiorenal prognosis in patients with renoprotective treatments: A systematic review and meta‐analysisShuzhen Bai, Linong Ji, Xiaoling Cai et al.|Journal of Evidence-Based Medicine|2024Cited by 1